-
1
-
-
33644948128
-
Rapid loss of striatal VMAT2 binding associated with onset of Lewy body dementia
-
Albin R, Koeppe R. Rapid loss of striatal VMAT2 binding associated with onset of Lewy body dementia. Mov Disord. 2006;21:287-288.
-
(2006)
Mov Disord
, vol.21
, pp. 287-288
-
-
Albin, R.1
Koeppe, R.2
-
2
-
-
0030796597
-
In vivo radiotracers for vesicular neurotransmitter transporters
-
Kilbourn MR. In vivo radiotracers for vesicular neurotransmitter transporters. Nucl Med Biol. 1997;24:615-619.
-
(1997)
Nucl Med Biol
, vol.24
, pp. 615-619
-
-
Kilbourn, M.R.1
-
3
-
-
19944432710
-
The role of radiotracer imaging in Parkinson disease
-
Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64:208-215.
-
(2005)
Neurology
, vol.64
, pp. 208-215
-
-
Ravina, B.1
Eidelberg, D.2
Ahlskog, J.E.3
-
4
-
-
33645993639
-
Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis
-
Van Laere K, Casteels C, De CL, et al. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. J Nucl Med. 2006;47:384-392.
-
(2006)
J Nucl Med
, vol.47
, pp. 384-392
-
-
Van Laere, K.1
Casteels, C.2
De, C.L.3
-
5
-
-
0033625124
-
99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers
-
99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med. 2000;41:584-589.
-
(2000)
J Nucl Med
, vol.41
, pp. 584-589
-
-
Mozley, P.D.1
Schneider, J.S.2
Acton, P.D.3
-
6
-
-
0037208654
-
Dopamine receptors in Parkinson's disease: Imaging studies
-
Stoessl AJ. de lF-F. Dopamine receptors in Parkinson's disease: imaging studies. Adv Neurol. 2003;91:65-71.
-
(2003)
Adv Neurol
, vol.91
, pp. 65-71
-
-
Stoessl, A.J.D.L.F.-F.1
-
8
-
-
0030511826
-
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging
-
Frey KA, Koeppe RA, Kilbourn MR, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol. 1996;40:873-884.
-
(1996)
Ann Neurol
, vol.40
, pp. 873-884
-
-
Frey, K.A.1
Koeppe, R.A.2
Kilbourn, M.R.3
-
9
-
-
0042125047
-
Increased ventral striatal monoaminergic innervation in Tourette syndrome
-
Albin RL, Koeppe RA, Bohnen NI, et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 2003;61:310-315.
-
(2003)
Neurology
, vol.61
, pp. 310-315
-
-
Albin, R.L.1
Koeppe, R.A.2
Bohnen, N.I.3
-
10
-
-
33747348188
-
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease
-
Bohnen NI, Albin RL, Koeppe RA, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006;26:1198-1212.
-
(2006)
J Cereb Blood Flow Metab
, vol.26
, pp. 1198-1212
-
-
Bohnen, N.I.1
Albin, R.L.2
Koeppe, R.A.3
-
11
-
-
0036583564
-
Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease?
-
Frey KA. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Eur J Nucl Med Mol Imaging. 2002;29:715-717.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 715-717
-
-
Frey, K.A.1
-
12
-
-
10044247418
-
Lack of regional selectivity during the progression of Parkinson disease: Implications for pathogenesis
-
Lee CS, Schulzer M, de la Fuente-Fernández R, et al. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol. 2004;61:1920-1925.
-
(2004)
Arch Neurol
, vol.61
, pp. 1920-1925
-
-
Lee, C.S.1
Schulzer, M.2
De La Fuente-Fernández, R.3
-
13
-
-
0030152867
-
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
-
Kilbourn MR, Frey KA, Vander BT, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl Med Biol. 1996;23:467-471.
-
(1996)
Nucl Med Biol
, vol.23
, pp. 467-471
-
-
Kilbourn, M.R.1
Frey, K.A.2
Vander, B.T.3
Sherman, P.S.4
-
14
-
-
0033966874
-
Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice
-
Kilbourn MR, Kuszpit K, Sherman P. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Synapse. 2000;35:250-255.
-
(2000)
Synapse
, vol.35
, pp. 250-255
-
-
Kilbourn, M.R.1
Kuszpit, K.2
Sherman, P.3
-
15
-
-
33747354108
-
Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters
-
Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Nucl Med Biol. 2006;33: 685-694.
-
(2006)
Nucl Med Biol
, vol.33
, pp. 685-694
-
-
Goswami, R.1
Ponde, D.E.2
Kung, M.P.3
Hou, C.4
Kilbourn, M.R.5
Kung, H.F.6
-
16
-
-
33947305764
-
Characterization of optically resolved 9-fluoropropyl- dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters
-
Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Nucl Med Biol. 2007;34:239-246.
-
(2007)
Nucl Med Biol
, vol.34
, pp. 239-246
-
-
Kung, M.P.1
Hou, C.2
Goswami, R.3
Ponde, D.E.4
Kilbourn, M.R.5
Kung, H.F.6
-
17
-
-
33947319832
-
18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain
-
18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain. Nucl Med Biol. 2007;34:233-237.
-
(2007)
Nucl Med Biol
, vol.34
, pp. 233-237
-
-
Kilbourn, M.R.1
Hockley, B.2
Lee, L.3
-
19
-
-
0036266804
-
Striatal monoaminergic terminals in lewy body and Alzheimer's dementias
-
DOI 10.1002/ana.10186
-
Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Ann Neurol. 2002;51:767-771. (Pubitemid 34568857)
-
(2002)
Annals of Neurology
, vol.51
, Issue.6
, pp. 767-771
-
-
Suzuki, M.1
Desmond, T.J.2
Albin, R.L.3
Frey, K.A.4
-
21
-
-
77952552594
-
18F]AV-45, a novel amyloid imaging agent: A pilot study
-
18F]AV-45, a novel amyloid imaging agent: a pilot study. Nucl Med Biol. 2010;37:497-508.
-
(2010)
Nucl Med Biol
, vol.37
, pp. 497-508
-
-
Lin, K.J.1
Hsu, W.C.2
Hsiao, I.T.3
-
22
-
-
23044470017
-
OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine
-
Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
-
(2005)
J Nucl Med
, vol.46
, pp. 1023-1027
-
-
Stabin, M.G.1
Sparks, R.B.2
Crowe, E.3
-
23
-
-
0003733260
-
-
International Commission on Radiological Protection (ICRP). ICRP Publication 60. New York, NY: Pergamon Press
-
International Commission on Radiological Protection (ICRP). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. New York, NY: Pergamon Press; 1991.
-
(1991)
1990 Recommendations of the International Commission on Radiological Protection
-
-
-
24
-
-
33644939201
-
Brain SPECT imaging and whole-body biodistribution with [123I]A
-
Lin KJ, Liu CY, Wey SP, et al. Brain SPECT imaging and whole-body biodistribution with [123I]A. Nucl Med Biol. 2006;33:193-202.
-
(2006)
Nucl Med Biol
, vol.33
, pp. 193-202
-
-
Lin, K.J.1
Liu, C.Y.2
Wey, S.P.3
-
26
-
-
0003618858
-
-
International Commission on Radiological Protection (ICRP). ICRP Publication 30. Oxford, U.K.: Pergamon Press
-
International Commission on Radiological Protection (ICRP). Part 1: Limits for Intakes of Radionuclides by Workers. ICRP Publication 30. Oxford, U.K.: Pergamon Press; 1979.
-
(1979)
Part 1: Limits for Intakes of Radionuclides by Workers
-
-
-
29
-
-
0029562331
-
PET radiopharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics (SPCs)
-
Meyer GJ, Waters SL, Coenen HH, Luxen A, Maziere B, Langstrom B. PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs). Eur J Nucl Med. 1995;22:1420-1432.
-
(1995)
Eur J Nucl Med
, vol.22
, pp. 1420-1432
-
-
Meyer, G.J.1
Waters, S.L.2
Coenen, H.H.3
Luxen, A.4
Maziere, B.5
Langstrom, B.6
-
30
-
-
0022647428
-
The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders
-
Roberts MS, McLean S, Millingen KS, Galloway HM. The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders. Eur J Clin Pharmacol. 1986;29:703-708.
-
(1986)
Eur J Clin Pharmacol
, vol.29
, pp. 703-708
-
-
Roberts, M.S.1
McLean, S.2
Millingen, K.S.3
Galloway, H.M.4
-
31
-
-
0023093007
-
Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies
-
Mehvar R, Jamali F, Watson MW, Skelton D. Pharmacokinetics of tetrabenazine and its major metabolite in man and rat: bioavailability and dose dependency studies. Drug Metab Dispos. 1987;15:250-255. (Pubitemid 17056771)
-
(1987)
Drug Metabolism and Disposition
, vol.15
, Issue.2
, pp. 250-255
-
-
Mehvar, R.1
Jamali, F.2
Watson, W.B.3
Skelton, D.4
-
32
-
-
40949132162
-
11C]-dihydrotetrabenazine imaging of baboons: Biodistribution and human radiation dosimetry estimates
-
11C]- dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates. Eur J Nucl Med Mol Imaging. 2008;35:790-797.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 790-797
-
-
Murthy, R.1
Harris, P.2
Simpson, N.3
-
33
-
-
46749097973
-
18F-FP-(+)- DTBZ: A potential PET ligand for studying diabetes mellitus
-
18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. J Nucl Med. 2008;49:1171-1176.
-
(2008)
J Nucl Med
, vol.49
, pp. 1171-1176
-
-
Kung, M.P.1
Hou, C.2
Lieberman, B.P.3
-
34
-
-
0042244323
-
Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors
-
Anlauf M, Eissele R, Schafer MK, et al. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cytochem. 2003;51:1027-1040.
-
(2003)
J Histochem Cytochem
, vol.51
, pp. 1027-1040
-
-
Anlauf, M.1
Eissele, R.2
Schafer, M.K.3
-
35
-
-
77952551571
-
Binding characteristics of 9-fluoropropyl- (+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats
-
Tsao HH, Lin KJ, Juang JH, et al. Binding characteristics of 9-fluoropropyl- (+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats. Nucl Med Biol. 2010;37:413-419.
-
(2010)
Nucl Med Biol
, vol.37
, pp. 413-419
-
-
Tsao, H.H.1
Lin, K.J.2
Juang, J.H.3
-
36
-
-
0033668692
-
Chemical neuroanatomy of the vesicular amine transporters
-
Weihe E, Eiden LE. Chemical neuroanatomy of the vesicular amine transporters. FASEB J. 2000;14:2435-2449.
-
(2000)
FASEB J
, vol.14
, pp. 2435-2449
-
-
Weihe, E.1
Eiden, L.E.2
|